About
Small Molecule Discovery
Areas of Focus
Categories
Small Molecule PharmaceuticalNJ, NY, PA
Team (5)
Bryan Sendrowski
Bryan Sendrowski
Melinta Therapeutics
team_member
Christine Ann Miller
Christine Ann Miller
Melinta Therapeutics
team_member
Doug Girgenti
Doug Girgenti, M.D.
Melinta Therapeutics
team_member
Jonathan Leff
Jonathan Leff
Melinta Therapeutics
team_member
Sumner Anderson
Sumner Anderson
Melinta Therapeutics
team_member
Clinical Trials (37)
View allTotal Trials
37
As Lead Sponsor
34
As Collaborator
3
Total Enrollment
9,742
By Phase
PHASE3: 12PHASE1: 14PHASE2: 9PHASE2/PHASE3: 1
By Status
COMPLETED: 28TERMINATED: 4WITHDRAWN: 2ENROLLING_BY_INVITATION: 1RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline37 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06774144Collaborator
Rezafungin Prophylaxis in Liver Transplant
PHASE3Enrolling by invitation
385 participants
Started: Oct 15, 2025 · Completed: Dec 31, 2028
NCT06329518Collaborator
Rezafungin Pharmacokinetics in Patients on ECMO
PHASE1Withdrawn
Started: Jul 1, 2024 · Completed: Dec 11, 2024
NCT06612255Lead Sponsor
A Study Comparing the Bioavailability of a Taste-masked Delafloxacin Powder for Oral Suspension With the Delafloxacin Tablet in Healthy Adults
PHASE1Terminated
16 participants
Started: Jun 3, 2024 · Completed: Sep 11, 2024
NCT05599295Lead Sponsor
Study to Evaluate the Safety of Intravenous Oritavancin for the Treatment of Children With Skin Infections
PHASE2Recruiting
75 participants
Started: Jun 15, 2023 · Completed: Jan 15, 2026
NCT03873987Lead Sponsor
Relative Exposure and Safety Study of Kimyrsa in ABSSSI Patients
PHASE1Completed
102 participants
Started: Jul 16, 2019 · Completed: Sep 4, 2019
Locations (1)
Headquarters
Parsippany, NJ, United States
Map
Loading map...